Nina Feldman

Philadelphia formally cut ties with 9-month-old Philly Fighting COVID on Monday. There were clear warning signs much earlier, some say.

Penn, Temple and Einstein are pivoting from Phase 1A, when they vaccinated their patient-facing staff, to Phase 1B, their most at-risk patients.

After PFC turned away people seeking vaccinations that day, friends of CEO Andrei Doroshin say they saw a Snapchat photo of him appearing to administer vaccine off-site.

Philadelphia says it has cut ties with the 9-month-old mass vaccine distributor over its sudden switch to a for-profit model and abrupt drop of community testing partners.

Many in the city’s medical community were surprised when Philly Fighting COVID opened a mass vaccination site — and stopped offering free neighborhood tests.

More than 60,000 people have already entered information at Philly Fighting COVID’s site. The city says the data won’t be shared because it isn’t an official registry.

“Bring them here to help us,” said Black Doctors COVID-19 Consortium founder Dr. Ala Stanford, speaking Monday at Girard College’s MLK Day of Service.

The highly transmissible B.1.1.7 variant of the SARS-Cov-2 virus was found in a woman in her 50s. She is now recovering.

Reversing the decision of a federal judge in Philadelphia, the appeals court panel ruled, 2-1, that Safehouse would violate U.S. law.

The 2-day mass-vaccination site is for health workers unassociated with hospitals. The hope is to even out the racial distribution of vaccine recipients.

Part of the delay in delivering results may not be because of overwhelming test volume at labs, but slow communication to patients.

Officials blame hospital logistics for the slow rollout of the COVID-19 vaccine process in Pennsylvania, New Jersey and Delaware.